First Quarter M&A Activity Rose On The Strength Of Three Deals

Merger
Bolt-on acquisitions remained the order of the day in Q1, despite one $14bn+ deal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Strategy